{
  "timestamp": "2026-01-05T07:16:59.076196",
  "agent_id": "user_assist",
  "phase": "complete",
  "input_data": null,
  "prompt": null,
  "llm_response": null,
  "output_data": {
    "summary": "Follow-up session detailing severe worsening of depressive symptoms, focusing on anhedonia, sleep disturbance, functional impairment, and passive suicidal ideation.",
    "clinical_nature": "follow-up",
    "validation_result": "approved",
    "reasoning": "Patient presents four weeks post-initiation of *Sertraline* (50mg) with escalating symptoms, including early morning awakening, weight loss, and passive thoughts of death ('wish I could disappear'). The core focus was immediate safety clarification and subsequent medication optimization to *Sertraline* 100mg, ruling out *bipolar spectrum disorder* in the process."
  },
  "duration_ms": 4233,
  "error": null
}